Matches in Wikidata for { <http://www.wikidata.org/entity/Q83370829> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q83370829 description "2012 թվականին հրատարակված գիտական հոդված" @default.
- Q83370829 description "article scientifique publié en 2012" @default.
- Q83370829 description "artikull shkencor i botuar më 01 janar 2012" @default.
- Q83370829 description "artículu científicu espublizáu en xineru de 2012" @default.
- Q83370829 description "scientific article published on 01 January 2012" @default.
- Q83370829 description "wetenschappelijk artikel" @default.
- Q83370829 description "наукова стаття, опублікована в січні 2012" @default.
- Q83370829 description "научна статия" @default.
- Q83370829 name "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 name "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 name "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 type Item @default.
- Q83370829 label "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 label "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 label "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 prefLabel "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 prefLabel "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 prefLabel "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 P1433 Q83370829-F7C3BDBC-584A-4185-9F99-5A8AB6E32ED6 @default.
- Q83370829 P1476 Q83370829-BA6E63E9-E2D3-416B-B72A-7D0D39EBA2E0 @default.
- Q83370829 P2093 Q83370829-55BD2612-D060-4B54-880E-58DFBCC52EE0 @default.
- Q83370829 P2093 Q83370829-603DB833-F50E-4A0C-A7A0-7AEE84396C13 @default.
- Q83370829 P2093 Q83370829-6BD462BA-BB9D-4C59-A0FB-6CD023CCC4D7 @default.
- Q83370829 P2093 Q83370829-7DA4398B-728E-4A81-B4A9-08641096CEE6 @default.
- Q83370829 P2093 Q83370829-9CD32BFB-4993-42B2-B07F-0BD92128C3AF @default.
- Q83370829 P2093 Q83370829-A526511D-B324-4076-A1B1-E31B85C3791F @default.
- Q83370829 P2093 Q83370829-F1BCBC40-BDB9-4B47-97C7-FF55079DDAB3 @default.
- Q83370829 P304 Q83370829-36CB5186-C316-459F-9032-ABCDD7805510 @default.
- Q83370829 P31 Q83370829-4F8E1F03-54D7-4735-9078-2DB0521046D9 @default.
- Q83370829 P356 Q83370829-4AC1F062-8917-416A-ABC5-CD8E362605D9 @default.
- Q83370829 P433 Q83370829-63BEB514-F240-495F-B54F-0AE2480C4AA3 @default.
- Q83370829 P478 Q83370829-1C63BE03-37A3-46B5-BF7E-79D744137BC7 @default.
- Q83370829 P50 Q83370829-77E9F1F0-1E34-4A43-B395-E569EBF275A9 @default.
- Q83370829 P577 Q83370829-77FA2AFF-78E3-41CE-803E-AC0BAA4FFF3A @default.
- Q83370829 P698 Q83370829-328BA118-B458-47FF-860E-D3409EE9B787 @default.
- Q83370829 P921 Q83370829-4097FA56-BE08-4B34-B001-6AD51012634B @default.
- Q83370829 P356 EXPANIM.61.49 @default.
- Q83370829 P698 22293672 @default.
- Q83370829 P1433 Q15762367 @default.
- Q83370829 P1476 "A novel diabetes mellitus mouse model, MAFA-deficient and beta cell-specific MAFK-overexpressing hybrid transgenic mice, developed severe diabetic nephropathy and improved with TCV-116 (candesartan cilexetil) treatment" @default.
- Q83370829 P2093 "Akiko Fujita" @default.
- Q83370829 P2093 "Homare Shimohata" @default.
- Q83370829 P2093 "Keigyou Yoh" @default.
- Q83370829 P2093 "Masami Ojima" @default.
- Q83370829 P2093 "Midori Okamura" @default.
- Q83370829 P2093 "Naoki Morito" @default.
- Q83370829 P2093 "Satoru Takahashi" @default.
- Q83370829 P304 "49-57" @default.
- Q83370829 P31 Q13442814 @default.
- Q83370829 P356 "10.1538/EXPANIM.61.49" @default.
- Q83370829 P433 "1" @default.
- Q83370829 P478 "61" @default.
- Q83370829 P50 Q90045006 @default.
- Q83370829 P577 "2012-01-01T00:00:00Z" @default.
- Q83370829 P698 "22293672" @default.
- Q83370829 P921 Q1129105 @default.